P149 Evaluating outcomes for patients with systemic lupus erythematosus treated with obinutuzumab, a humanised anti-CD20 monoclonal antibody, following secondary non-depletion of B cells and non-response with rituximabVikram M K Joseph, Maria Leandro, Corinne Fisher et al.|Lara D. Veeken|2025Cited by 1